Know your five-year breast cancer risk. It's already in your mammogram.

Oprah Daily has updated its piece on AI-based breast cancer risk assessment to cover the nationwide launch of Clairity Breast through Everlywell and the NCCN guideline update on AI-powered mammogram risk assessment starting at age 35. Founder and CEO Dr. Connie Lehman and BCRF chief scientific officer Dr. Dorraya El-Ashry explain how an image-based five-year risk estimate differs from the question a mammogram answers today.

STAT examines why Clairity brought its breast cancer risk prediction directly to women rather than waiting for clinical adoption and reimbursement to catch up. The piece is part of STAT’s Paying for AI series on how new clinical AI tools affect affordability and access, and it opens on the nationwide launch with Everlywell.

Women’s Health examines the shift from age-based mammography to screening built around a woman’s individual risk, covering genetic testing, the WISDOM trial and AI tools that read risk signals from the mammogram image. Clairity Breast appears alongside them, with founder and CEO Dr. Connie Lehman on why identifying risk earlier lets clinicians find the younger women who need closer attention.